Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands
Open Access
- 15 August 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-18
Abstract
Glioblastoma (GBM) is a highly aggressive primary brain tumour and is resistant to nearly all available treatments, including natural killer (NK) cell immunotherapy. However, the factors mediating NK cell evasion in GBM remain largely unclear. Here, we report that EZH2-92aa, a protein encoded by circular EZH2, is overexpressed in GBM and induces the immune evasion of GBM stem cells (GSCs) from NK cells. Positively regulated by DEAD-box helicase 3 (DDX3), EZH2-92aa directly binds the major histocompatibility complex class I polypeptide-related sequence A/B (MICA/B) promoters and represses their transcription; it also indirectly represses UL16-binding protein (ULBP) transcription by stabilizing EZH2. The downregulation of NK group 2D ligands (NKG2DLs, including MICA/B and ULBPs) in GSCs mediates NK cell resistance. Moreover, stable EZH2-92aa knockdown enhances NK cell-mediated GSC eradication in vitro and in vivo and synergizes with anti-PD1 therapy. Our results highlight the immunosuppressive function of EZH2-92aa in inhibiting the NK cell response in GBM and the clinical potential of targeting EZH2-92aa for NK-cell-directed immune therapy.Keywords
This publication has 60 references indexed in Scilit:
- A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cellsNeuro-Oncology, 2013
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Regulation of Ligands for the NKG2D Activating ReceptorAnnual Review of Immunology, 2013
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Immune Infiltration of Spontaneous Mouse Astrocytomas Is Dominated by Immunosuppressive Cells from Early Stages of Tumor DevelopmentCancer Research, 2010
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in ExosomesCancer Research, 2010
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patientsNeuro-Oncology, 2009
- NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like PropertiesThe Journal of Immunology, 2009
- TGF- and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cellsBrain, 2006